Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: An analysis of the CERTIFY study

  • S.M. Schellong, H.-E. Gerlach, U. Tebbe, S. Haas, N. Melzer, C. Abletshauser, C. Sieder, P. Bramlage, H. Riess, R. Bauersachs
  • Thrombosis Research, November 2011, Elsevier
  • DOI: 10.1016/j.thromres.2011.05.002

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Peter Bramlage